McInnes, Iain B.
Buckley, Christopher D.
Isaacs, John D.
Article History
First Online: 10 December 2015
Competing interests
: I.B.M. declares that he has received research funding and honouraria from AbbVie, BMS, MSD, Pfizer, Roche and UCB, all of whom make biologic agents used in the treatment of rheumatoid arthritis. C.D.B. declares that he has received honouraria and research funding from Novartis, Pfizer, Roche and UCB. J.D.I. declares that he has received research funding and honouraria from AbbVie, BMS, Novartis, Janssen, Pfizer and Roche.